Towa Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.27% vs -1.08% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 126.86% vs -42.39% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "65,327.00",
          "val2": "65,149.00",
          "chgp": "0.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,894.00",
          "val2": "10,456.00",
          "chgp": "4.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "609.00",
          "val2": "540.00",
          "chgp": "12.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3,007.00",
          "val2": "-1,452.00",
          "chgp": "307.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,701.00",
          "val2": "2,513.00",
          "chgp": "126.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "80.20%",
          "val2": "79.90%",
          "chgp": "0.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "259,594.00",
          "val2": "227,934.00",
          "chgp": "13.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43,342.00",
          "val2": "35,536.00",
          "chgp": "21.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,627.00",
          "val2": "947.00",
          "chgp": "71.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1,209.00",
          "val2": "5,309.00",
          "chgp": "-77.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18,986.00",
          "val2": "16,173.00",
          "chgp": "17.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.50%",
          "val2": "77.40%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

65,327.00

65,149.00

0.27%

Operating Profit (PBDIT) excl Other Income

10,894.00

10,456.00

4.19%

Interest

609.00

540.00

12.78%

Exceptional Items

3,007.00

-1,452.00

307.09%

Consolidate Net Profit

5,701.00

2,513.00

126.86%

Operating Profit Margin (Excl OI)

80.20%

79.90%

0.03%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.27% vs -1.08% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 126.86% vs -42.39% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

259,594.00

227,934.00

13.89%

Operating Profit (PBDIT) excl Other Income

43,342.00

35,536.00

21.97%

Interest

1,627.00

947.00

71.81%

Exceptional Items

1,209.00

5,309.00

-77.23%

Consolidate Net Profit

18,986.00

16,173.00

17.39%

Operating Profit Margin (Excl OI)

89.50%

77.40%

1.21%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 13.89% vs 9.13% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 17.39% vs 634.80% in Mar 2024

All Annual Results